[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-06", "acceptance_datetime": "2025-11-06T21:25:14Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001658247-25-000019", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001658247-25-000019/files/crnx-20250930_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 60379000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "cash": {"value": 1100000000.0, "unit": "USD", "label": "Cash", "order": 210}, "assets": {"value": 1196031000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 1072169000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 1121275000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 6109000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 1072169000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 14377000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 68046000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 74155000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 21275000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities_and_equity": {"value": 1196031000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 123862000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 74756000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 49707000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 3084000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -110718000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 57175000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 57175000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 164809000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -110718000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 164809000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 3084000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"net_income_loss": {"value": -130091000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 52265000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 142729000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 130234000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_before_equity_method_investments": {"value": -130091000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "operating_income_loss": {"value": -142586000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -130091000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "depreciation_and_amortization": {"value": 1012000.0, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -130091000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_equity_method_investments": {"value": 0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "basic_earnings_per_share": {"value": -1.38, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -130091000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 90464000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 94215000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": 94215000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_after_tax": {"value": -130091000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "nonoperating_income_loss": {"value": 12495000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 130234000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 143000, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -1.38, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}, "comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": 573000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -129518000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 573000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -129518000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-07", "acceptance_datetime": "2025-08-07T20:39:31Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-175498", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-175498/files/crnx-20250630_htm.xml", "financials": {"income_statement": {"revenues": {"value": 1031000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -1.23, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "research_and_development": {"value": 80301000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -115637000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -115637000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "selling_general_and_administrative_expenses": {"value": 49842000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "nonoperating_income_loss": {"value": 13475000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "basic_earnings_per_share": {"value": -1.23, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -129112000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -115637000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "depreciation_and_amortization": {"value": 959000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 93791000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 93791000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -115637000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 130143000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 130143000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": 1031000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "balance_sheet": {"noncurrent_assets": {"value": 72310000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "cash": {"value": 1200000000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 1171526000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 1171526000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 68396000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 1217264000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 57071000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 118048000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_assets": {"value": 17264000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "assets": {"value": 1289574000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 57640000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 1289574000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 14670000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 11325000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": -381000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": -381000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -116018000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -116018000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -85851000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 37953000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 7055000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 37953000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 7055000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -40843000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -85851000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -40843000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-08", "acceptance_datetime": "2025-05-08T20:14:38Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-066982", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-066982/files/crnx-20250331_htm.xml", "financials": {"income_statement": {"diluted_earnings_per_share": {"value": -1.04, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -111405000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -96774000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_average_shares": {"value": 93102000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -1.04, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 111766000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": 361000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 361000, "unit": "USD", "label": "Revenues", "order": 100}, "selling_general_and_administrative_expenses": {"value": 35526000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "research_and_development": {"value": 76240000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -96774000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 111766000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_average_shares": {"value": 93102000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "nonoperating_income_loss": {"value": 14631000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -96774000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "depreciation_and_amortization": {"value": 925000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss_attributable_to_parent": {"value": -96774000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "cash_flow_statement": {"net_cash_flow": {"value": -169976000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -85961000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -169976000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -88452000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -88452000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 4437000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -85961000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 4437000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "balance_sheet": {"equity": {"value": 1254000000.0, "unit": "USD", "label": "Equity", "order": 1400}, "cash": {"value": 1300000000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 1361327000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 1361327000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 47469000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 70272000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 57311000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 12628000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 1254000000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 57644000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 1291055000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 107327000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 9842000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -95735000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 1039000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": 1039000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -95735000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-12", "acceptance_datetime": "2024-11-12T21:15:13Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-125420", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-125420/files/crnx-20240930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": 15107000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 57327000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 15107000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 57327000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -62823000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 20603000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 20603000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -62823000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"accounts_payable": {"value": 4939000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 53562000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 937374000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 832980000.0, "unit": "USD", "label": "Equity", "order": 1400}, "cash": {"value": 862700000.0, "unit": "USD", "label": "Cash", "order": 210}, "other_current_liabilities": {"value": 48623000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 832980000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 59787000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 104394000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 877587000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 937374000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 50832000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 11710000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_assets": {"value": 14887000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 48077000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -74600000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 2228000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -74600000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_average_shares": {"value": 80091000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -76828000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -76828000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": -0.96, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": -76828000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -76828000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 80091000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "nonoperating_income_loss": {"value": 10969000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 87797000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 87797000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "depreciation_and_amortization": {"value": 770000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "research_and_development": {"value": 61905000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -87797000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 25892000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.96, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -76828000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-08", "acceptance_datetime": "2024-08-08T20:13:11Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-093977", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-093977/files/crnx-20240630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 5496000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -45617000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -93762000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -53641000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -53641000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -45617000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 5496000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -93762000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "revenues": {"value": 399000, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 58344000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 24838000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 79008000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "nonoperating_income_loss": {"value": 8728000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_earnings_per_share": {"value": -0.94, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -74055000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 83182000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -74055000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -82783000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.94, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "costs_and_expenses": {"value": 83182000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "depreciation_and_amortization": {"value": 753000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "income_loss_from_continuing_operations_after_tax": {"value": -74055000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -74055000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 79008000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": 399000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -74395000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -340000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -74395000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"other_noncurrent_assets": {"value": 48512000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 45505000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "cash": {"value": 863000000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity": {"value": 830763000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 935535000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 8872000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 54377000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 11776000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities": {"value": 104772000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 935535000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 60759000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 874776000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 830763000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 12247000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-09", "acceptance_datetime": "2024-05-09T20:38:18Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-057150", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-057150/files/crnx-20240331_htm.xml", "financials": {"income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -66930000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 72289000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 53341000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -66930000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -66930000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": 640000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -73529000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_earnings_per_share": {"value": -0.93, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 20354000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 72289000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -0.93, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "depreciation_and_amortization": {"value": 474000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "revenues": {"value": 640000, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -66930000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "nonoperating_income_loss": {"value": 7069000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 74169000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 74169000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -52856000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 393574000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 309000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 309000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 341027000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 341027000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -52856000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 393574000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"assets": {"value": 978153000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 917228000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 10756000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 60925000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "cash": {"value": 901000000.0, "unit": "USD", "label": "Cash", "order": 210}, "liabilities": {"value": 103220000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 874933000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 874933000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_assets": {"value": 16228000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 49060000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 51767000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 41011000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 11865000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 978153000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -827000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -67757000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -67757000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 635353000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 6548000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 43942000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 539106000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 539106000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 37394000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 10881000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "cash": {"value": 558600000.0, "unit": "USD", "label": "Cash", "order": 210}, "noncurrent_assets": {"value": 61200000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 635353000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 52305000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 96247000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 50319000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_assets": {"value": 15553000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 574153000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -58255000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -7974000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -58255000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -87898000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -87898000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 37925000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -38515000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -87308000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -38515000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 37925000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -87308000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"benefits_costs_expenses": {"value": 218542000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 3068000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -62658000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -60097000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -60097000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.8799999999999999, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "research_and_development": {"value": 45580000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 54579000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -60097000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -60097000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 62658000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "depreciation_and_amortization": {"value": 262000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -218542000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": 6762000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_earnings_per_share": {"value": -0.8799999999999999, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_average_shares": {"value": 3068000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 16816000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-07", "acceptance_datetime": "2023-11-07T21:11:27Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-060254", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-060254/files/crnx-20230930_htm.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 641537000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 34621000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 53326000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_assets": {"value": 21060000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_assets": {"value": 65777000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 575760000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 40463000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 93789000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 641537000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 547748000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 56013000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 5842000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 9764000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "cash": {"value": 554700000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 547748000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -193296000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -41339000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -41339000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 103242000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 337877000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -193296000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 337877000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 103242000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"research_and_development": {"value": 43839000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 15484000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -58977000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -57458000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 59323000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "nonoperating_income_loss": {"value": 2516000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_parent": {"value": -57458000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 346000, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": 346000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 56808000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -57458000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 59323000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -1.01, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -57458000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "depreciation_and_amortization": {"value": 273000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "basic_earnings_per_share": {"value": -1.01, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 56808000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -56618000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 840000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -56618000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-08", "acceptance_datetime": "2023-08-08T11:07:10Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-039350", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-039350/files/crnx-20230630_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_parent": {"value": 254116000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 27765000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 293254000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 284810000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_assets": {"value": 20310000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": 254116000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 39138000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 293254000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "cash": {"value": 264500000.0, "unit": "USD", "label": "Cash", "order": 210}, "fixed_assets": {"value": 3223000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 32610000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 5221000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 4845000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 8444000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -50170000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -50170000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 809000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 12658000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 31436000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 31436000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 12658000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -45735000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -45735000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -1641000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -1641000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"costs_and_expenses": {"value": 53983000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -52995000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 53983000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "nonoperating_income_loss": {"value": 2016000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "other_operating_expenses": {"value": 13343000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "depreciation_and_amortization": {"value": 280000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": -0.94, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -50979000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -50979000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "revenues": {"value": 988000, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.94, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": 988000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -50979000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 54275000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": 54275000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 40640000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -50979000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-09", "acceptance_datetime": "2023-05-09T20:56:05Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-019821", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-019821/files/crnx-20230331_htm.xml", "financials": {"balance_sheet": {"other_current_liabilities": {"value": 20426000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 26321000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 3266000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "cash": {"value": 296100000.0, "unit": "USD", "label": "Cash", "order": 210}, "noncurrent_assets": {"value": 8606000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 33679000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 314009000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 5895000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 280330000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 5340000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_assets": {"value": 9303000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 305403000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 314009000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 280330000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -40718000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 48755000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -40718000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 484000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 8521000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 8521000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 484000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 48755000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -1417000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -44578000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -44578000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -47978000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_average_shares": {"value": 53908000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 53908000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_earnings_per_share": {"value": -0.85, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": -45995000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "nonoperating_income_loss": {"value": 1983000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -45995000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -45995000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -45995000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 50657000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.85, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "depreciation_and_amortization": {"value": 283000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "costs_and_expenses": {"value": 50657000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": 2679000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 38468000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 11906000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 2679000.0, "unit": "USD", "label": "Revenues", "order": 100}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 115000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 1761000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 36853000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -35207000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -35207000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 1761000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 115000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 36853000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -8177000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -43912000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -43912000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"other_noncurrent_assets": {"value": 3492000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 352176000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_assets": {"value": 10784000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 316328000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 8125000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 316328000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "cash": {"value": 334400000.0, "unit": "USD", "label": "Cash", "order": 210}, "liabilities_and_equity": {"value": 352176000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 345184000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 6883000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 27723000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 20840000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 6992000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 35848000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 3500000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "income_statement": {"other_operating_expenses": {"value": 10994000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "depreciation_and_amortization": {"value": 280000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "operating_income_loss": {"value": -47556000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 48265000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -44991000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -0.8300000000000001, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": 626000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 709000, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 36991000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -44991000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.8300000000000001, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -44991000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 626000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "nonoperating_income_loss": {"value": 2565000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_before_tax": {"value": -167946000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 168655000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -44991000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 44301000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-14", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-024736", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-024736/files/crnx-20220930_htm.xml", "financials": {"balance_sheet": {"other_current_assets": {"value": 9923000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 2993000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "cash": {"value": 368400000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_liabilities": {"value": 24556000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 3564000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 351372000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 384880000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 5877000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 33508000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 384880000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 8952000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 351372000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 6557000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 18679000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 378323000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "income_statement": {"basic_average_shares": {"value": 53768000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "nonoperating_income_loss": {"value": 1529000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 43912000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -41925000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.78, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "research_and_development": {"value": 31987000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 11925000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": 458000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 458000, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -43454000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 53768000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 43912000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": -0.78, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -41925000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -41925000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "depreciation_and_amortization": {"value": 248000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss_available_to_common_stockholders_basic": {"value": -41925000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -43316000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -43316000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 1391000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 1076000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -38479000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -38479000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -30581000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 1076000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 6822000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -30581000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 6822000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-12", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-017020", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-017020/files/crnx-20220630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -27976000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 118992000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -27976000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -174271000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 118992000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -83255000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -83255000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -174271000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 52522000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "depreciation_and_amortization": {"value": 215000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "income_loss_from_continuing_operations_before_tax": {"value": -42375000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -42375000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -42375000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 32995000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 43484000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.81, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -43045000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_earnings_per_share": {"value": -0.81, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_after_tax": {"value": -42375000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "nonoperating_income_loss": {"value": 670000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "other_operating_expenses": {"value": 10489000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "costs_and_expenses": {"value": 43484000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 439000, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 42814000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 52522000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -42375000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 17076000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 386165000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 416285000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 421733000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 3152000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_assets": {"value": 7785000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": 386165000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "cash": {"value": 408500000.0, "unit": "USD", "label": "Cash", "order": 210}, "assets": {"value": 421733000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 35568000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 9039000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 2296000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 26115000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 5448000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -43802000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -43802000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 1427000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-12", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-009740", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-009740/files/crnx-20220331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 1780000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 1780000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -55147000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -43384000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -55147000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -43384000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -13543000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -13543000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"other_operating_expenses": {"value": 8466000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_average_shares": {"value": -2392000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -34627000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -34627000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": 3131000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -33827000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 3131000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": -2392000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 28252000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 36958000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.73, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "nonoperating_income_loss": {"value": 210000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "basic_earnings_per_share": {"value": -0.73, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "depreciation_and_amortization": {"value": 240000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "costs_and_expenses": {"value": 36958000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -34627000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -34627000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 333286000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_assets": {"value": 8549000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 328249000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 5037000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 30242000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 2672000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 2365000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 303044000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 303044000.0, "unit": "USD", "label": "Equity", "order": 1400}, "cash": {"value": 319700000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_liabilities": {"value": 20257000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 333286000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -1810000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -36437000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -36437000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "financials": {"balance_sheet": {"other_current_assets": {"value": 11020000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 344720000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 15995000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 351015000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 3076000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 3470000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 331944000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 2825000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 331944000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 19071000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 6295000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "cash": {"value": 333700000.0, "unit": "USD", "label": "Cash", "order": 210}, "assets": {"value": 351015000.0, "unit": "USD", "label": "Assets", "order": 100}}, "cash_flow_statement": {"net_cash_flow": {"value": 39159000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 163856000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -22899000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 39159000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -101798000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 163856000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -101798000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -22899000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -30794000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -30794000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 7127000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "nonoperating_income_loss": {"value": 94000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -30794000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 1078000.0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 31966000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -30794000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "depreciation_and_amortization": {"value": 235000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "operating_income_loss": {"value": -30888000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 24604000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -30794000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -31164000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -31164000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -370000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-05", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-054747", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-054747/files/crnx-10q_20210930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -7025000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -17235000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -25673000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 15463000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -7025000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 15463000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -17235000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -25673000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -22000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -27873000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -27873000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -27851000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 21580000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": -44000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_before_tax": {"value": -27851000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -27851000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "depreciation_and_amortization": {"value": 233000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss": {"value": -27851000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 6227000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -27851000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 27807000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -27807000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "balance_sheet": {"other_current_assets": {"value": 10673000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": 193590000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 209359000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 2483000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 5386000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 15769000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "cash": {"value": 193300000.0, "unit": "USD", "label": "Cash", "order": 210}, "liabilities_and_equity": {"value": 209359000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 193590000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 203973000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 12440000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 3329000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 2903000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-10", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-043078", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-043078/files/crnx-10q_20210630_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -9000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -26104000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -26104000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"depreciation_and_amortization": {"value": 230000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "other_operating_expenses": {"value": 5602000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -26095000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -26095000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -26089000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 26089000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -26095000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -26095000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "nonoperating_income_loss": {"value": -6000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -26095000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 20487000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "balance_sheet": {"equity_attributable_to_parent": {"value": 201440000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 216929000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 211355000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 15489000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 201440000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 5574000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 216929000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 11919000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "cash": {"value": 203800000.0, "unit": "USD", "label": "Cash", "order": 210}, "fixed_assets": {"value": 3005000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_assets": {"value": 7555000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 2569000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 73192000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 73303000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -19949000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -19949000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 73303000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 73192000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 19838000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 19838000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-06", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-024927", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-024927/files/crnx-10q_20210331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 32502000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 32502000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -20067000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -20067000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 12492000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 57000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 12492000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 57000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -22907000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -6000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -22907000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"fixed_assets": {"value": 3005000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 149480000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 10264000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 5746000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 163550000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 157804000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 149480000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 2652000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 14070000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_assets": {"value": 7104000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "assets": {"value": 163550000.0, "unit": "USD", "label": "Assets", "order": 100}, "cash": {"value": 150700000.0, "unit": "USD", "label": "Cash", "order": 210}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -22901000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -22901000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -22901000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "nonoperating_income_loss": {"value": 17000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "other_operating_expenses": {"value": 5110000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 22918000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "depreciation_and_amortization": {"value": 224000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "research_and_development": {"value": 17584000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -22918000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -22901000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -22901000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "financials": {"income_statement": {"operating_expenses": {"value": 21791000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -73883000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -21791000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": 20650000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -21641000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -21641000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 4736000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -21641000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 16830000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 73883000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": 150000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "depreciation_and_amortization": {"value": 225000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "net_income_loss": {"value": -21641000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 97000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -15938000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 97000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -15938000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -8892000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -24733000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -24733000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -8892000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -21660000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -21660000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -19000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"current_assets": {"value": 177492000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 183445000.0, "unit": "USD", "label": "Assets", "order": 100}, "cash": {"value": 170900000.0, "unit": "USD", "label": "Cash", "order": 210}, "noncurrent_liabilities": {"value": 4037000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 5953000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 168919000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 168919000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 2772000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 14526000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 10489000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 3181000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 183445000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_assets": {"value": 6592000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}}}}, {"start_date": "2020-07-01", "end_date": "2020-09-30", "filing_date": "2020-11-06", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2020", "cik": "0001658247", "sic": "2834", "tickers": ["CRNX"], "company_name": "Crinetics Pharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-20-051686", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-20-051686/files/crnx-10q_20200930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -18403000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -83000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -18403000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -18320000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -18320000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -18451000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 4752000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "depreciation_and_amortization": {"value": 244000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 13699000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -18320000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 18451000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -18320000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 18451000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -18320000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "nonoperating_income_loss": {"value": 131000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -24832000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -18004000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -24832000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -18004000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": -158000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -42994000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -42994000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -158000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 187222000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 187222000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 194122000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 13095000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 3389000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 2806000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_assets": {"value": 7322000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities_and_equity": {"value": 200317000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 4262000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 200317000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 8833000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 6195000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "cash": {"value": 186800000.0, "unit": "USD", "label": "Cash", "order": 210}}}}]